Flufenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) within the anthranilic acid derivative class that acts as a cyclooxygenase (COX) inhibitor to reduce pain and inflammation by blocking… Read more
Flufenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) within the anthranilic acid derivative class that acts as a cyclooxygenase (COX) inhibitor to reduce pain and inflammation by blocking prostaglandin synthesis. Primarily indicated for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and dysmenorrhea, this compound requires rigorous analytical oversight throughout its lifecycle. This category provides essential reference standards, including the active pharmaceutical ingredient, identified degradation products, process-related impurities, and the metabolite Flufenamic Acid Glucuronide. These materials are critical for pharmaceutical laboratories performing impurity profiling and method validation. Additionally, stable isotope labelled compounds, such as Flufenamic Acid-d4, serve as internal standards for precise quantification during mass spectrometry analysis. By utilizing these high-quality reference materials, researchers and quality control scientists can ensure accurate monitoring of product purity, stability, and safety compliance in various analytical testing environments.